Natixis Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.6M Buy
719,472
+689,185
+2,276% +$21.7M 0.03% 454
2025
Q4
$892K Buy
30,287
+13,762
+83% +$382K ﹤0.01% 1296
2025
Q3
$417K Buy
+16,525
New +$403K ﹤0.01% 1533
2025
Q1
Sell
-20,595
Closed -$521K 1670
2024
Q4
$521K Sell
20,595
-85,314
-81% -$2.16M ﹤0.01% 1460
2024
Q3
$2.64M Sell
105,909
-175,407
-62% -$5.19M 0.01% 998
2024
Q2
$8.34M Buy
281,316
+60,552
+27% +$1.68M 0.02% 659
2024
Q1
$6.66M Buy
220,764
+209,703
+1,896% +$5.82M 0.02% 725
2023
Q4
$316K Sell
11,061
-3,906
-26% -$115K ﹤0.01% 1460
2023
Q3
$555K Buy
14,967
+1,097
+8% +$41.9K ﹤0.01% 1337
2023
Q2
$541K Buy
13,870
+120
+0.9% +$4.7K ﹤0.01% 1318
2023
Q1
$502K Sell
13,750
-1,148
-8% -$36.2K ﹤0.01% 1307
2022
Q4
$459K Buy
+14,898
New +$462K ﹤0.01% 1316

Other funds holding RTO

Natixis Advisors's RTO Position: Q1 2026 in Review

Natixis Advisors increased its Rentokil (RTO) stake by 2,276% in Q1 2026, buying an estimated $21.7M and bringing the position to 719,472 shares worth $22.6M. The position accounts for 0.03% of the portfolio, ranked #454.

Natixis Advisors first reported a position in RTO in Q4 2022 and has held it in 12 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Natixis Advisors held 719,472 shares of Rentokil worth $22.6M as of Q1 2026.
  • Natixis Advisors bought 689,185 Rentokil shares in Q1 2026, an estimated $21.7M.
  • Rentokil made up 0.03% of Natixis Advisors's portfolio in Q1 2026, its #454 holding.
  • Natixis Advisors first reported a position in Rentokil in Q4 2022 and has held it in 12 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.